Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancer.
作者信息
Kuo Hung-Yang, Guo Jhe-Cyuan, Hsu Chih-Hung
机构信息
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
出版信息
J Formos Med Assoc. 2023 Jan;122(1):4-8. doi: 10.1016/j.jfma.2022.05.009. Epub 2022 Jun 6.
PMID:35680471
Abstract
摘要
Zotero 插件